- $473.31m
- $549.31m
- $170.44m
Regenxbio climbs as new director buys nearly $1 million of stock
Brief: Regenxbio Strengthens Board Of Directors With Appointment Of Greg Ciongoli
U.S. STOCKS ON THE MOVE-Strategy, Ecovyst, Azenta
U.S. STOCKS ON THE MOVE-Azenta, Qiagen NV, Capricor Therapeutics
Regenxbio plunges as FDA places hold on Hunter syndrome gene therapy
Regenxbio plunges as FDA places hold on Hunter syndrome gene therapy
FDA places clinical hold on Regenxbio's gene therapy for Hunter Syndrome (updated)
FDA places clinical hold on Regenxbio's gene therapy for Hunter Syndrome
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:00 AM
Trump picks White House adviser Heidi Overton to run FDA, source says (updated)
Earnings Summary
Regenxbio Q2 revenue surges on AbbVie milestone payment
Brief: Regenxbio Q2 Operating Expenses USD 78.756 Million
Earnings Preview
Regenxbio Inc expected to post earnings of 6 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE -Apple, Travelers, Intuitive Surgical
U.S. STOCKS ON THE MOVE -Nvidia, Intuitive Surgical, SpaceX
U.S. STOCKS ON THE MOVE-Apple, Travelers, Intuitive Surgical
Regenxbio tumbles on deep-discounted $100 mln equity offering